The “all hands on deck” responses to the Covid-19 pandemic have driven significant innovations in areas ranging from vaccine development and drug repurposing to diagnostic and antibody testing, telemedicine and contact tracing. At the same time, the pandemic has also prompted a relook at things like global supply chains, PPE strategic reserves and just in time inventories. Speakers and panelists will discuss preparations for future pandemics as well as the effects on current healthcare.
Agenda
| Time | Event |
|---|---|
| Registration and Breakfast | |
| 9:15-9:30am | Welcome and Introduction Dan Peterson, Vice President, Industry & Government Affairs, Cook Group |
| 9:30-10:15am | Keynote Lindsay Weaver, MD, FACEP, Chief Medical Officer, Indiana State Department of Health |
| 10:15 – 10:30am | Break |
| 10:30am – 12:00 pm | Panel – Five Things Going Forward Moderator: Neal Roach, Health Care & Life Sciences Industry Chair, Taft Stettinius & Hollister LLP Chris Otto, Senior Director, Clinical Laboratory Services, Eli Lilly and Company Erica Anderson, Population Health Strategy Lead, Office of Population Health, Humana Denis Johnson, Vice President and General Manager, Catalent Pharma Solutions Chris Kiple, CEO, Ventec Life Systems Rusty Ring, Vice President Government Affairs, Roche Diagnostics |
| 12:00-12:05 pm | Wrap-up and Transition to Breakouts George Telthorst, Director, Center for the Business of Life Sciences, IU-Kelley School of Business |
| 12:05 – 12:15 pm | Break |
| 12:15-1:00 pm | Breakout Session(s) Over Lunch with the morning speakers |
